Unraveling the Inflammatory Enigma: Is Neuroinflammation a Culprit or Consequence in Pharmacoresistant Epilepsy?
Brain and Behavior · 2026
DOI: 10.1002/brb3.71657 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain and Behavior, 2026. Verfasst von Xianmei Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Emergency Department, the Affiliated Hospital of Guizhou Medical University, Guiyang City, Guizhou Province, China. Hauptthemen laut MEDLINE: Drug Resistant Epilepsy, Neuroinflammatory Diseases, Status Epilepticus, Inflammation. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the key Advantageous Discipline Construction Project of Guizhou Provincial Health Commission in 2023 in Emergency Department, Key lab of acute brain injury and function repair in Guizhou Medical University, Leading Discipline Program of the Affiliated Hospital of Guizhou Medical University.
Abstract (Originalsprache)
Background
Approximately 30% of epilepsy patients develop pharmacoresistant epilepsy (PRE), characterized by persistent seizures refractory to antiseizure medications (ASMs). While neuroinflammation is implicated in both epileptogenesis and treatment failure, its precise temporal contribution remains unclear. This study aimed to delineate the distinct roles of acute versus chronic neuroinflammation in seizure susceptibility and the maintenance of drug resistance.
Methods
Male Sprague‐Dawley rats received acute inflammatory priming via systemic (intraperitoneal) or intracranial (hippocampal) lipopolysaccharide (LPS) administration prior to lithium‐pilocarpine‐induced status epilepticus (SE). Rats were subsequently classified as PRE or pharmacosensitive epilepsy (PSE) based on their response to two sequentially administered ASMs. Outcomes were assessed using video‐EEG monitoring, hippocampal cytokine profiling (IL‐6 and TNF‐α), histopathological analysis of neuronal damage, and peripheral inflammatory markers.
Results
Acute inflammatory priming significantly lowered the threshold for SE induction ( P < 0.05); however, it did not increase the proportion of PRE ( P > 0.05). In contrast, established PRE was characterized by sustained hippocampal neuroinflammation, with markedly elevated IL‐6 and TNF‐α levels compared to PSE and control groups, alongside severe neuronal loss.
Conclusion
These findings reveal a temporal dissociation in the roles of neuroinflammation: acute inflammation acts as a potent initiator of epileptogenesis, whereas chronic, sustained inflammation coincides with the drug‐resistant phenotype. This study refines the prevailing view of neuroinflammation from a static pathogenic factor to a dynamic, phase‐dependent modulator, supporting the rationale for stage‐targeted strategies in PRE. Notably, putative mechanisms linking inflammation to resistance, such as impaired efferocytosis, warrant future experimental validation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Emergency Department, the Affiliated Hospital of Guizhou Medical University, Guiyang City, Guizhou Province, China.
- School of Nursing, Guizhou Medical University, Guiyang City, Guizhou Province, China.
- Key Laboratory of Endemic and Ethnic Diseases of the Ministry of Education, Guiyang City, Guizhou Province, China.
- The Second Affiliated Hospital of Guizhou University of Traditional Chinese Medicine, Guiyang, Guizhou Province, China.
ORCID-Profile: Xianmei Wang
Förderung
- the key Advantageous Discipline Construction Project of Guizhou Provincial Health Commission in 2023 in Emergency Department
- Key lab of acute brain injury and function repair in Guizhou Medical University
- Leading Discipline Program of the Affiliated Hospital of Guizhou Medical University
- the Natural Science Foundation of China
- the Research Start-up Fund Project for High-level Talents of Guizhou Medical University
- the Teaching Research Funding Project of the Affiliated Hospital of Guizhou Medical University (School of Clinical Medicine)
- the National Natural Science Foundation Cultivation Program of Guizhou Medical University
- the 2025 Annual Scientific Research Project of Guizhou Provincial Nursing Association
Zitieren
APA
Wang, X., Deng, J., Shi, D., Liu, Z., Wang, L., & Wu, G. (2026). Unraveling the Inflammatory Enigma: Is Neuroinflammation a Culprit or Consequence in Pharmacoresistant Epilepsy?. Brain and Behavior. https://doi.org/10.1002/brb3.71657
Vancouver
Wang X, Deng J, Shi D, Liu Z, Wang L, Wu G. Unraveling the Inflammatory Enigma: Is Neuroinflammation a Culprit or Consequence in Pharmacoresistant Epilepsy?. Brain and Behavior. 2026. doi:10.1002/brb3.71657
BibTeX
@article{Wang2026,
author = {Wang, Xianmei and Deng, Jie and Shi, Dai and Liu, Zhiyan and Wang, Likun and Wu, Guofeng},
title = {Unraveling the Inflammatory Enigma: Is Neuroinflammation a Culprit or Consequence in Pharmacoresistant Epilepsy?},
journal = {Brain and Behavior},
year = {2026},
doi = {10.1002/brb3.71657}
}
EUVIMED